Nogo signaling and non-physical injury-induced nervous system pathology

Journal of Neuroscience Research

Volumn 79, Issue 3, 2005, Pages 273-278

  Teng, Felicia Yu Hsuan ^a   Tang, Bor Luen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Amyotrophic lateral sclerosis (ALS); Epilepsy; Experimental autoimmune encephalomyelitis (EAE); Nogo; Nogo 66 receptor (NgR)

Indexed keywords

PROTEIN NOGO; PROTEIN NOGO A;

ALLERGIC ENCEPHALOMYELITIS; AMYOTROPHIC LATERAL SCLEROSIS; AUTOIMMUNE DISEASE; BRAIN TISSUE; DEMYELINATING DISEASE; HUMAN; IMMUNIZATION; MUSCLE TISSUE; MYELINATION; NERVE REGENERATION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROPATHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCHIZOPHRENIA; SHORT SURVEY; SIGNAL TRANSDUCTION; TEMPORAL LOBE EPILEPSY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPILEPSY; HUMANS; MYELIN PROTEINS; NERVE DEGENERATION; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 14044257857     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20361     Document Type: Short Survey

References (68)

1. Acevedo L, Yu J, Erdjument-Bromage H, Miao RQ, Kim JE, Fulton D, Tempst P, Strittmatter SM, Sessa WC. 2004. A new role for Nogo as a regulator of vascular remodeling. Nat Med 10:382-388.
2. Bandtlow CE, Dlaska M, Pirker S, Czech T, Baumgartner C, Sperk G. 2004. Increased expression of Nogo-A in hippocampal neurons of patients with temporal lobe epilepsy. Eur J Neurosci 20:195-206.
3. Bareyre FM, Haudenschild B, Schwab ME. 2002. Long-lasting sprouting and gene expression changes induced by the monoclonal antibody IN-1 in the adult spinal cord. J Neurosci 22:7097-7110.
4. Barker BA. 2004. p75NTR is positively promiscuous: novel partners and new insights. Neuron 42:529-533.
5. Bernard CC, Johns TG, Slavin A, Ichikawa M, Ewing C, Liu J, Bettadapura J. 1997. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J Mol Med 75:77-88.
6. Bhat MA, Rios JC, Lu Y, Garcia-Fresco GP, Ching W, St Martin M, Li J, Einheber S, Chesler M, Rosenbluth J, Salzer JL, Bellen HJ. 2001. Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV/Caspr/Paranodin. Neuron 30:369-383.
7. Bohm D, Schwegler H, Kotthaus L, Nayernia K, Rickmann M, Kohler M, Rosenbusch J, Engel W, Flugge G, Burfeind P. 2002. Disruption of PLC-beta 1-mediated signal transduction in mutant mice causes age-dependent hippocampal mossy fiber sprouting and neurodegeneration. Mol Cell Neurosci 21:584-601.
8. Caroni P, Schwab ME. 1988. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1:85-96.
9. Chen MS, Huber AB, Van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME. 2000. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403:434-439.
10. Dickson BJ. 2002. Molecular mechanisms of axon guidance. Science 298: 1959-1964.
11. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, Kimura N, Cai H, Deng K, Gao Y, He Z, Filbin M. 2002. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 35:283-290.
12. Dupuis L, Gonzalez de Aguilar JL, Di Scala F, Rene F, De Tapia M, Pradat PF, Lacomblez L, Seihlan D, Prinjha R, Walsh FS, Meininger V, Loeffler JP. 2002. Nogo provides a molecular marker for diagnosis of amyotrophic lateral sclerosis. Neurobiol Dis 10:358-365.
13. Emerick AJ, Neafsey EJ, Schwab ME, Kartje GL. 2003. Functional reorganization of the motor cortex in adult rats after cortical lesion and treatment with monoclonal antibody IN-1. J Neurosci 23:4826-4830.
14. Etienne-Manneville S, Hall A. 2002. Rho GTPases in cell biology. Nature 420:629-635.
15. Fiedler M, Horn C, Bandtlow C, Schwab ME, Skerra A. 2002. An engineered IN-1 F(ab) fragment with improved affinity for the Nogo-A axonal growth inhibitor permits immunochemical detection and shows enhanced neutralizing activity. Protein Eng 15:931-941.
16. Fouad K, Dietz V, Schwab ME. 2001. Improving axonal growth and functional recovery after experimental spinal cord injury by neutralizing myelin associated inhibitors. Brain Res Brain Res Rev 36:204-212.
17. Fournier AE, GrandPre T, Gould G, Wang X, Strittmatter SM. 2002. Nogo and the Nogo 66 receptor. Prog Brain Res 137:361-369.
18. Fournier AE, GrandPre T, Strittmatter SM. 2001. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409:341-346.
19. Gentry JJ, Barker PA, Carter BD. 2004. The p75 neurotrophin receptor: multiple interactors and numerous functions. Prog Brain Res 146:25-39.
20. GrandPre T, Li S, Strittmatter SM. 2002. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417:547-551.
21. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. 2000. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403:439-444.
22. Hasegawa Y, Fujitani M, Hata K, Tohyama M, Yamagishi S, Yamashita T. 2004. Promotion of axon regeneration by myelin-associated glycoprotein and Nogo through divergent signals downstream of Gi/G. J Neurosci 24:6826-6832.
23. Huber AB, Weinmann O, Brosamle C, Oertle T, Schwab ME. 2002. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 22:3553-3567.
24. Hunt D, Coffin RS, Anderson PN. 2002a. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review. J Neurocytol 31:93-120.
25. Hunt D, Coffin RS, Prinjha RK, Campbell G, Anderson PN. 2003. Nogo-A expression in the intact and injured nervous system. Mol Cell Neurosci 24:1083-1102.
26. Hunt D, Mason MR, Campbell G, Coffin R, Anderson PN. 2002b. Nogo receptor mRNA expression in intact and regenerating CNS neurons. Mol Cell Neurosci 20:537-552.
27. Josephson A, Trifunovski A, Scheele C, Widenfalk J, Wahlestedt C, Brene S, Olson L, Spenger C. 2003. Activity-induced and developmental downregulation of the Nogo receptor. Cell Tissue Res 311:333-342.
28. Josephson A, Widenfalk J, Widmer HW, Olson L, Spenger C. 2001. NOGO mRNA expression in adult and fetal human and rat nervous tissue and in weight drop injury. Exp Neurol 169:319-328.
29. Karnezis T, Mandemakers W, McQualter JL, Zheng B, Ho PP, Jordan KA, Murray BM, Barres B, Tessier-Lavigne M, Bernard CC. 2004. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosci 7:736-744.
30. Kim JE, Li S, GrandPre T, Qiu D, Strittmatter SM. 2003. Axon regeneration in young adult mice lacking Nogo-A/B. Neuron 38:187-199.
31. Lee JK, Kim JE, Sivula M, Strittmatter SM. 2004. Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci 24:6209-6217.
32. Lee DH, Strittmatter SM, Sah DW. 2003. Targeting the Nogo receptor to treat central nervous system injuries. Nat Rev Drug Discov 2:872-878.
33. Li Q, Qi B, Oka K, Shimakage M, Yoshioka N, Inoue H, Hakura A, Kodama K, Stanbridge EJ, Yutsudo M. 2001. Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene 20: 3929-3936.
34. Li, S, Strittmatter SM. 2003. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci 23:4219-4227.
35. Liu YY, Jin WL, Liu HL, Ju G. 2003. Electron microscopic localization of Nogo-A at the postsynaptic active zone of the rat. Neurosci Lett 346: 153-156.
36. Liu H, Ng CEL, Tang BL. 2002. Nogo-A expression in mouse central nervous system neurons. Neurosci Lett 328:257-260.
37. Mingorance A, Fontana X, Sole M, Burgaya F, Urena JM, Teng FY, Tang BL, Hunt D, Anderson PN, Bethea JR, Schwab ME, Soriano E, del Rio JA. 2004. Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions. Mol Cell Neurosci 26:34-49.
38. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM, Pepinsky RB. 2004. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7:221-228.
39. Nagaike K, Mikoshiba K, Tsukada Y. 1982. Dysmyelination of shiverer mutant mice in vivo and in vitro. J Neurochem 39:1235-1241.
40. Niederost B, Oertle T, Fritsche J, McKinney RA, Bandtlow CE. 2002. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci 22: 10368-10376.
41. Nie DY, Zhou ZH, Ang BT, Teng FY, Xu G, Xiang T, Wang CY, Zeng L, Takeda Y, Xu TL, Ng YK, Faivre-Sarrailh C, Popko B, Ling EA, Schachner M, Watanabe K, Fallen CJ, Tang BL, Xiao ZC. 2003. Nogo-A at CNS paranodes is a ligand of Caspr: possible regulation of potassium channel localization. EMBO J 22:5666-5678.
42. Ng CEL, Tang BL. 2002. Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron regeneration. J Neurosci Res 67:559-565.
43. Novak G, Kim D, Seeman P, Tallerico T. 2002. Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res Mol Brain Res 107:183-189.
44. Oertle T, Merkler D, Schwab ME. 2003a. Do cancer cells die because of Nogo-B? Oncogene 22:1390-1399.
45. Oertle T, Schwab ME. 2003. Nogo and its paRTNers. Trends Cell Biol 13:187-194.
46. Oertle T, Van der Haar ME, Bandtlow CE, Robeva A, Burfeind P, Buss A, Huber AB, Simonen M, Schnell L, Brosamle C, Kaupmann K, Vallon R, Schwab ME. 2003b. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 23:5393-5406.
47. Olofsson B. 1999. Rho guanine dissociation inhibitors: pivotal molecules in cellular signaling. Cell Signal 11:545-554.
48. Papadopoulos CM, Tsai SY, Alsbiei T, O'Brien TE, Schwab ME, Kartje GL. 2002. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol 51:433-441.
49. Peles E, Nativ M, Lustig M, Grumet M, Schilling J, Martinez R, Plowman GD, Schlessinger J. 1997. Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. EMBO J 16:978-988.
50. Prinjha R, Moore SE, Vinson M, Blake S, Morrow R, Christie G, Michalovich D, Simmons DL, Walsh FS. 2000. Inhibitor of neurite outgrowth in humans. Nature 403:383-384.
51. Rasband MN. 2004. It's "juxta" potassium channel! J Neurosci Res 76: 749-757.
52. Reindl M, Khantane S, Ehling R, Schanda K, Lutterotti A, Brinkhoff C, Oertle T, Schwab ME, Deisenhammer F, Berger T, Bandtlow CE. 2003. Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders. J Neuroimmunol 145:139-147.
53. Schwab ME. 2004. Nogo and axon regeneration. Curr Opin Neurobiol 14:118-124.
54. Simonen M, Pedersen V, Weinmann O, Schnell L, Buss A, Ledermann B, Christ F, Sansig G, Van der Putten H, Schwab ME. 2003. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 38: 201-211.
55. NTR does not promote regeneration of injured spinal cord in mice. J Neurosci 24:542-546.
56. Strittmatter SM. 2002. Modulation of axonal regeneration in neurodegenerative disease: focus on Nogo. J Mol Neurosci 19:117-121.
57. Tagami S, Eguchi Y, Kinoshita M, Takeda M, Tsujimoto Y. 2000. A novel protein, RTN-XS, interacts with both Bel-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene 19:5736-5746.
58. Tatagiba M, Rosahl S, Gharabaghi A, Blomer U, Brandis A, Skerra A, Samii M, Schwab ME. 2002. Regeneration of auditory nerve following complete sectioning and intrathecal application of the IN-1 antibody. Acta Neurochir (Wien) 144:181-187.
59. Teng FY, Ling BM, Tang BL. 2004. Inter- and intracellular interactions of Nogo: new findings and hypothesis. J Neurochem 89:801-806.
60. Wang KC, Kim JA, Sivasankaran R, Segal R, He Z. 2002a. p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420:74-78.
61. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z. 2002b. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417:941-944.
62. Wang X, Chun SJ, Treloar H, Vartanian T, Greer CA, Strittmatter SM. 2002c. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 22:5505-5515.
63. Wiessner C, Bareyre FM, Allegrini PR, Mir AK, Frentzel S, Zurini M, Schnell L, Oertle T, Schwab ME. 2003. Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab 23:154-165.
64. Wong ST, Henley JR, Kanning KC, Huang M, Bothwell M, Poo MM. 2002. A p75 (NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 5:1302-1308.
65. Woolf CJ. 2003. No Nogo: now where to go? Neuron 38:153-156.
66. Yamashita T, Tohyama M. 2003. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci 6:461-467.
67. Yiu G, He Z. 2003. Signaling mechanisms of the myelin inhibitors of axon regeneration. Curr Opin Neurobiol 13:545-551.
68. Zheng B, Ho C, Li S, Keirstead H, Steward O, Tessier-Lavigne M. 2003. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 38:213-224.